These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3097893)

  • 1. Comparison of the immunosuppressive effects of cyclosporine, lipid-soluble anesthetics, and calmodulin antagonists. Response to exogenous interleukin 2.
    LeGrue SJ; Munn CG
    Transplantation; 1986 Dec; 42(6):679-85. PubMed ID: 3097893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the binding of cyclosporine to calmodulin result in immunosuppression?
    LeGrue SJ; Turner R; Weisbrodt N; Dedman JR
    Science; 1986 Oct; 234(4772):68-71. PubMed ID: 3749892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis.
    Kermani-Arab V; Salehmoghaddam S; Danovitch G; Hirji K; Rezai A
    Transplantation; 1985 Apr; 39(4):439-42. PubMed ID: 3920796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle.
    Asano M
    J Pharmacol Exp Ther; 1989 Nov; 251(2):764-73. PubMed ID: 2810127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes.
    Prince HE; John JK
    Immunol Invest; 1986 Aug; 15(5):463-72. PubMed ID: 3096881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism of immunosuppression mediated by ethanol.
    Kaplan DR
    Cell Immunol; 1986 Oct; 102(1):1-9. PubMed ID: 3100053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists.
    Colombani PM; Bright EC; Monastyrskyj O; Hess AD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1171-4. PubMed ID: 2950628
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus.
    Kasaian MT; Biron CA
    J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.
    Harris DT; Kozumbo WJ; Cerutti PA; Cerottini JC
    Cell Immunol; 1987 Oct; 109(1):104-14. PubMed ID: 3115596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of calmodulin blockers on membrane potential, potassium permeability and lymphocyte mitogenesis].
    Gukovskaia AS; Zinchenko VP; Astashkin EI
    Biokhimiia; 1985 May; 50(5):786-94. PubMed ID: 3924125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporine on interleukin 2 receptor expression in a human alloreactive T cell clone.
    Chabannes D; Le Mauff B; Hallet MM; Yacques Y; Soulillou JP
    Transplantation; 1988 Aug; 46(2 Suppl):97S-100S. PubMed ID: 3136569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory activity of cyclosporine is dependent on the activating signal(s) provided to T cells.
    Suthanthiran M
    J Pediatr; 1987 Dec; 111(6 Pt 2):1008-11. PubMed ID: 2960793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G; Zimmerman TP
    Mol Pharmacol; 1984 Sep; 26(2):286-92. PubMed ID: 6482875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.